Condition: Lennox Gastaut Syndrome · Sponsor: Epygenix
This is a multicenter, Phase 3, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of clemizole HCL (EPX-100) as adjunctive therapy in children and adult participants with Lennox-Gastaut syndrome (LGS).
This description comes directly from the study's public registry record.
Juby Philip · (302) 559-4320 · clinicaltrials@harmonybiosciences.com
Cindy Sandy · (317) 258-7262 · clinicaltrials@harmonybiosciences.com
Always discuss trial participation with your own doctor first.
| Arkansas Children's Hospital | Little Rock, Arkansas, United States | Active Not Recruiting |
| UC Irvine Medical Center | Orange, California, United States | Active Not Recruiting |
| UCI Center for Innovative Health Therapies | Orange, California, United States | Recruiting |
| Nemours Children's Health | Wilmington, Delaware, United States | Not Yet Recruiting |
| Rare Disease Research | Kissimmee, Florida, United States | Suspended |
| University of Miami Miller School of Medicine | Miami, Florida, United States | Recruiting |
| AdventHealth Innovation Tower | Orlando, Florida, United States | Recruiting |
| Pediatric Neurology and Epilepsy Specialists | Winter Park, Florida, United States | Active Not Recruiting |
| Re:Cognition Health | Chicago, Illinois, United States | Recruiting |
| Norton Children's Medical Center | Louisville, Kentucky, United States | Active Not Recruiting |
| Henry Ford Hospital | Detroit, Michigan, United States | Active Not Recruiting |
| Minnesota Epilepsy Group, P.A. | Roseville, Minnesota, United States | Active Not Recruiting |
+ 14 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05066217